Literature DB >> 22871141

Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs.

André B da Fonseca Antunes1, Bruno G De Geest, Chris Vervaet, Jean Paul Remon.   

Abstract

Here, we aim to evaluate Gelucire 44/14 as non-ionic surface-active excipient to produce immediate-release solid dosage forms for poorly water-soluble drugs. Gelucires are polyethylene glycol (PEG) glycerides composed of mono-, di- and triglycerides and mono- and diesters of PEG. They are inert semi-solid waxy amphiphilic excipients with surface-active properties that spontaneously form a fine dispersion or emulsion upon contact with water. Monolithic Gelucire 44/14 structures are prone to prolonged erosion times, thereby slowing down drug dissolution. To overcome this issue, we combine either granulation or spray-drying, followed by compression into tablets, with an optimized composition of disintegration promoting agents. This formulation strategy allows obtaining nearly 100% drug release within 10 min dissolution time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871141     DOI: 10.3109/03639045.2012.709251

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

1.  Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.

Authors:  Basmah N Aldosari; Alanood S Almurshedi; Iman M Alfagih; Bushra T AlQuadeib; Mohammad A Altamimi; Syed Sarim Imam; Afzal Hussain; Faleh Alqahtani; Ehab Elzayat; Sultan Alshehri
Journal:  AAPS PharmSciTech       Date:  2021-05-24       Impact factor: 4.026

Review 2.  Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.

Authors:  Karin Becker; Sharareh Salar-Behzadi; Andreas Zimmer
Journal:  Pharm Res       Date:  2015-03-19       Impact factor: 4.200

Review 3.  Twin-Screw Melt Granulation for Oral Solid Pharmaceutical Products.

Authors:  Seth P Forster; Erin Dippold; Tiffany Chiang
Journal:  Pharmaceutics       Date:  2021-05-06       Impact factor: 6.321

4.  Chitosan and chitosan chlorhydrate based various approaches for enhancement of dissolution rate of carvedilol.

Authors:  Amol S Shete; Adhikrao V Yadav; Srinivasa M Murthy
Journal:  Daru       Date:  2012-12-13       Impact factor: 3.117

5.  Design of olanzapine/lutrol solid dispersions of improved stability and performances.

Authors:  Cristina Cavallari; Adamo Fini; Giancarlo Ceschel
Journal:  Pharmaceutics       Date:  2013-10-25       Impact factor: 6.321

6.  Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations.

Authors:  Paola Mura; Francesca Maestrelli; Mario D'Ambrosio; Cristina Luceri; Marzia Cirri
Journal:  Pharmaceutics       Date:  2021-03-24       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.